{"id":56052,"date":"2016-03-15T12:33:02","date_gmt":"2016-03-15T12:33:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=56052"},"modified":"2016-03-15T12:33:02","modified_gmt":"2016-03-15T12:33:02","slug":"europe-real-time-polymerase-chain-reaction-compitative-forecast-to-2022-through-industry-instrument-and-regional-outlook","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/europe-real-time-polymerase-chain-reaction-compitative-forecast-to-2022-through-industry-instrument-and-regional-outlook_56052.html","title":{"rendered":"Europe Real Time Polymerase Chain Reaction Competative Forecast to 2022 Through Industry, Instrument and Regional Outlook"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Get key Market Research Reports and Insightful Company Profiles”<\/div>\n<\/div>\n<\/div>\n
Latest Research on “Europe Real Time Polymerase Chain Reaction” Technological advancements on the grounds of accuracy, portability, and cost-effectiveness are expected to serve this market as high-impact rendering drivers over the forecast period. For instance, Applied Biosystems has QuantStudio Dx series for rapid and affordable diagnosis of molecular abnormalities at early stage of diseases development. <\/div>\n

Europe Real Time Polymerase Chain Reaction (qPCR) market<\/strong><\/em> is expected to reach over USD 395.8 million by 2022, according to a new report by Grand View Research Inc. Technological advancements on the grounds of accuracy, portability, and cost-effectiveness are expected to serve this market as high-impact rendering drivers over the forecast period. For instance, Applied Biosystems has QuantStudio Dx series for rapid and affordable diagnosis of molecular abnormalities at early stage of diseases development. <\/p>\n

Increasing amount of R&D expenditure by the major players and development of novel assay kits are expected to provide potential growth platform for adoption of qPCR instruments for diagnostic use.<\/p>\n

Growing prevalence of cancer and other chronic diseases is anticipated to be the key driver for the industry growth. Moreover, growing geriatric population base in EU-28 countries is expected to increase age-related conditions such as diabetes and cardiovascular disorders. <\/strong><\/p>\n

Browse Detailed Report With TOC at:
<\/strong>http:\/\/www.hexareports.com\/report\/europe-real-time-polymerase-chain-reaction-market\/details<\/a> <\/p>\n

Further key findings from the study suggest:<\/strong><\/p>\n

Thermo Fisher\/ABI dominated the market with a revenue share of over 38% in 2014 owing to high installed base of instruments such as StepOne, 7500, ViiA 7, and QuantStudio from ABI Bio-Rad qPCR instruments market is the second largest in terms of revenue share over USD 7.0 million in 2014. Presence of licensing agreement with companies such as Mobidiag in Europe for the distribution Bio-Rad qPCR instruments, availability of user-friendly software and good technical support are some factors attributing for its high market coverage.<\/p>\n

Thermo Fischer Scientific, Roche, Bio-Rad, and Qiagen accounted for over 84% of market share in 2014. Product development and distribution agreements are the key strategies adopted by the company for its growth. Whereas, the four countries namely UK, Germany, Spain and France covered around 56% of the total European market for qPCR used as IVD platform in 2014.<\/p>\n

Related Reports By Hexa Reports:<\/strong><\/p>\n

Healthcare Payer BPO Market at:
<\/strong>http:\/\/www.hexareports.com\/report\/healthcare-payer-bpo-market-size-forecast-by-service\/details<\/a><\/p>\n

Global Allergic Rhinitis Drugs Market 2016 at:
<\/strong>http:\/\/www.hexareports.com\/report\/global-allergic-rhinitis-drugs-market-2016-2020\/details<\/a><\/p>\n

Germany dominated the European market with revenue of around USD 9.5 million in 2014. It is estimated to be one of the major countries for use of In-Vitro Diagnostics (IVD) platform in Europe.<\/p>\n

The UK is expected to witness significant growth with a CAGR of around 13% over the forecast period owing to rising prevalence of target diseases and introduction of new automated technologies. <\/strong><\/p>\n


Table Of Contents:<\/strong>
<\/strong><\/p>\n

Chapter 1 Methodology and Scope<\/strong> <\/strong><\/p>\n

Chapter 2 Executive Summary<\/strong><\/p>\n

Chapter 3 Europe Real Time Polymerase Chain Reaction (qPCR) Industry Outlook<\/strong><\/p>\n

Chapter 4 Europe Real Time Polymerase Chain Reaction (qPCR) Instrument Outlook<\/strong><\/p>\n

Chapter 5 Europe Real Time Polymerase Chain Reaction (qPCR) Regional Outlook<\/strong> <\/strong><\/p>\n


Request A Sample Copy of This Report at:
<\/strong>http:\/\/www.hexareports.com\/sample\/98178<\/a><\/p>\n


About Us:<\/strong><\/p>\n

Hexa Reports<\/a> is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. <\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Hexa Reports
Contact Person:<\/strong> Ryan Shaw
Email:<\/strong> sales@hexareports.com
Phone:<\/strong> 1-800-489-3075
Address:<\/strong>Felton Office Plaza, 6265 Highway 9
City:<\/strong> Felton
State:<\/strong> California
Country:<\/strong> United States
Website:<\/strong> http:\/\/www.hexareports.com\/report\/europe-real-time-polymerase-chain-reaction-market\/details<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Get key Market Research Reports and Insightful Company Profiles” Latest Research on “Europe Real Time Polymerase Chain Reaction” Technological advancements on the grounds of accuracy, portability, and cost-effectiveness are expected to serve this market as high-impact rendering drivers over the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-56052","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/56052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=56052"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/56052\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=56052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=56052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=56052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}